Company Filing History:
Years Active: 2022
Title: Joanna Rejman: Innovator in Nucleic Acid Delivery Systems
Introduction
Joanna Rejman is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. Her innovative work focuses on developing effective methods for delivering nucleic acid compounds, which are crucial for various therapeutic applications.
Latest Patents
Joanna Rejman holds a patent for "Hybrid carriers for nucleic acid cargo." This invention provides a composition for the delivery of a nucleic acid compound, which includes a cationic peptide or polymer and a lipidoid compound. The nucleic acid compound can be any chemically modified or unmodified DNA or RNA. The composition is designed to have a low amount of lipidoid relative to the cationic peptide or polymer, enhancing the efficiency of nucleic acid delivery.
Career Highlights
Joanna Rejman is currently associated with CureVac AG, a leading company in the field of mRNA technology. Her work at CureVac AG has positioned her as a key player in advancing innovative solutions for gene therapy and vaccine development.
Collaborations
Some of her notable coworkers include Patrick Baumhof and Carolin Thiele, who contribute to the collaborative environment at CureVac AG. Their combined expertise fosters a culture of innovation and excellence in research and development.
Conclusion
Joanna Rejman's contributions to nucleic acid delivery systems exemplify her dedication to advancing biotechnology. Her innovative patent and work at CureVac AG highlight her role as a leading inventor in this critical field.